Related Experiment Videos
[Glucagonoma--somatostatinoma]
1II. Medizinische Klinik, Klinikum rechts der Isar der Techn. Universität München.
Zeitschrift Fur Gastroenterologie
|August 13, 1999
Summary
Glucagonoma and somatostatinoma are rare tumors causing distinct syndromes due to hormone overproduction. Surgical removal is the primary treatment, with medications like interferon-alfa used for symptom management and metastasis control.
Area of Science:
- Endocrinology and Oncology
- Neuroendocrine Tumors
Context:
- Focuses on glucagonoma and somatostatinoma, rare neuroendocrine tumors.
- Explains clinical manifestations arising from excessive hormone secretion.
Purpose:
- To describe the characteristic syndromes of glucagonoma and somatostatinoma.
- To outline current therapeutic strategies for these conditions.
Summary:
- Glucagonoma syndrome presents with diabetes and characteristic skin lesions.
- Somatostatinoma syndrome often involves diabetes and steatorrhea.
- Surgical resection is the primary treatment; interferon-alfa and somatostatin analogs aid in symptom control and metastasis inhibition.
Impact:
- Provides a concise overview for clinicians managing these rare tumors.
- Highlights the importance of early diagnosis and multimodal treatment approaches.
- Informs therapeutic decisions regarding surgical and medical interventions.